PID2022-137372OR-C2: Novel antivirals against West Nile virus (WNV) infection targeting key events in viral replication and cellular factors
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14160%2F23%3A00133330" target="_blank" >RIV/00216224:14160/23:00133330 - isvavai.cz</a>
Výsledek na webu
—
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
PID2022-137372OR-C2: Novel antivirals against West Nile virus (WNV) infection targeting key events in viral replication and cellular factors
Popis výsledku v původním jazyce
West Nile virus (WNV) infection causes febrile, sometimes very serious and even fatal diseases. The outbreak of the virus includes Africa, Middle East, West Asia, Australia, North America, but it has also spread to southern, eastern or western Europe. The infection is transmitted via the bite of infected mosquitoes. In more than three-quarters of cases, the infection is asymptomatic, however, flu-like symptoms are observed in approx. 20% of those infected and, in some cases, severe neurological symptoms can develop, which can end fatally. Unfortunately, there is still no specific treatment, so this project focuses on the identification of new molecules that could be used as new substances with an antiviral effect.
Název v anglickém jazyce
PID2022-137372OR-C2: Novel antivirals against West Nile virus (WNV) infection targeting key events in viral replication and cellular factors
Popis výsledku anglicky
West Nile virus (WNV) infection causes febrile, sometimes very serious and even fatal diseases. The outbreak of the virus includes Africa, Middle East, West Asia, Australia, North America, but it has also spread to southern, eastern or western Europe. The infection is transmitted via the bite of infected mosquitoes. In more than three-quarters of cases, the infection is asymptomatic, however, flu-like symptoms are observed in approx. 20% of those infected and, in some cases, severe neurological symptoms can develop, which can end fatally. Unfortunately, there is still no specific treatment, so this project focuses on the identification of new molecules that could be used as new substances with an antiviral effect.
Klasifikace
Druh
O - Ostatní výsledky
CEP obor
—
OECD FORD obor
30104 - Pharmacology and pharmacy
Návaznosti výsledku
Projekt
—
Návaznosti
S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2023
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů